[1] AmitAlexander et al., “Approaches for breaking the barriers of drug permeation through transdermal drug delivery”, Journal of Controlled Release, Volume 164, Issue 1, 28 November 2012, Pages 26-40
[2] Matt Venus, Jacqueline Waterman, and Ian McNab, “Basic physiology of the skin, ” Surgery (Oxford), Volume 29, 2011 ,Pages 471-474
[3] Wickett R R, Visscher M O., “Structure and function of the epidermal barrier”, American Journal of Infection Control, Volume 34, 2006, Pages 98-110
[4] Boundless, “Structure of the Skin: Dermis.”, Boundless Anatomy and Physiology, 5, 1, 2016.Mark
[5] R. Prausnitz, Samir Mitragotri & Robert Langer, “Current status and future potential of transdermal drug delivery.”,Nature Reviews Drug Discovery,Volume 3,2004, Pages 115-124
[6] J. Lia, W. Xub, and Y. Lianga, et al., “The application of skin metabolomics in the context of transdermal drug delivery.”, Pharmacological Reports, Volume 69, 2017, Pages 252-259
[7] Daniels, Rolf. "Strategies for skin penetration enhancement." Strategies ,2010.
[8] B. W. Barry, "Novel mechanisms and devices to enable successful transdermal drug delivery," Eur J Pharm Sci, Volume 14, 2001, Pages 101-14
[9] K. Vávrová and A. Hrabálek, “Amino Acid-Based Transdermal Penetration Enhancers.”, Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement: Modification of the Stratum Corneum, Springer-Verlag Berlin Heidelberg, 20, 2015,Pages 325-336
[10] Pathan I. B., and Setty C. M., “Chemical Penetration Enhancers for Transdermal Drug Delivery Systems,” Tropical Journal of Pharmaceutical Research, Volume 8, No. 2, 2009, Pages 173-179.
[11] K.B. Ita, “Chemical penetration enhancers for transdermal drug delivery — success and challenges”,Curr. Drug Deliv., Volume 12,2015, Pages 645-651
[12] FL. Bamba, and J. Wepierre, “Role of the appendageal pathway in the percutaneous absorption of pyridostigmine bromide in various vehicles.” European Journal of Drug Metabolism and Pharmacokinetics, Volume18, 1993, Pages 339-348
[13] C.S Asbill, A.F El-Kattan, B Michniak, “Enhancement of transdermal drug delivery: chemical and physical approaches”,Crit. Rev. Ther. Drug Carrier Sys., Volume 17,2000, Pages 621-658
[14] Dhote V, Bhatnagar P, Mishra PK, et al., “ Iontophoresis: a potential emergence of a transdermal drug delivery system. ”, Sci Pharm ,Volume 80,2012,Pages 1–28
[15] A. Jadoul, J. Bouwstra, and V. Préat,“Effects of iontophoresis and electroporation on the stratum corneum Review of the biophysical studies.”, Advanced Drug Delivery Reviews, Volume 35, 1999 , Pages 89-105
[16] SM. Silva, L. Hu, and JJ. Sousa et al., “Michniak-Kohn BB. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.”, European Journal of Pharmaceutics and Biopharmaceutics, Volume 80, 2012 , Phages 663-673
[17] B. Zorec, V. Préat, and D. Miklavčič1 et al., “Active enhancement methods for intra- and transdermal drug delivery: a review.”, Zdrav Vestn, Volume 82, 2013, Pages 339-56
[18] J.C. Weaver, Y.A. Chizmadzhev, “Theory of electroporation: a review”, Bioelectrochemistry and Bioenergetics,Volume 41, Issue 2, December 1996, Pages 135-160
[19] Denet, A.R., Vanbever, R. & Preat, V. “Skin electroporation for transdermal and topical delivery. ”, Adv. Drug Deliv. Rev. ,Volume 56,2004, Pages 659–674
[20] K. Mori, T. Hasegawa, S. Sato, and K. Sugibayashi, “Effect of electric field on the enhanced skin permeation of drugs by electroporation.”, J Control Release, volume 90,2003, Pages 171-179
[21] Hui, S. W. , “Overview of Drug Delivery and Alternative Methods to Electroporation. ”, Methods Mol. Biol. , volume 423 ,2008, Pages 91–107.
[22] 陳思嘉,「靶向超音波於血栓溶解之研究」,碩士論文,國立台灣大學,台北 (2009)
[23] Wei, H., Bonald, B., Cai Q., Barnes, S. and wang, Y. ,“Antioxidant and antipromotional effect of the soybean isoflavone genistein ”,PSEBM, Volume 208, 1995, Pages 124-130
[24] N. B. Smith, “Perspectives on transdermal ultrasound mediated drug delivery. ” ,Int J Nanomedicine,Volume 2, 2007, Pages 585-94.
[25] Azagury A, Khoury L, Enden G, Kost J, “Ultrasound Mediated Transdermal Drug Delivery. ”Adv. Drug Deliv. Rev. , Volume 72,2014, Pages 127–143.
[26] Tin WuiWong,“Electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug delivery”, Journal of Controlled Release, Volume 193, 10 November 2014, Pages 257-269
[27] Ita K. ,“ Recent progress in transdermal sonophoresis. ”, Pharm. Dev. Technol. ,2015
[28] R.F. Donnelly, T.R. Singh, D.I. Morrow, A.D. Woolfson,“ Microneedle-mediated transdermal and intradermal drug delivery”,Wiley-Blackwell,Chichester, West Sussex ,2012
[29] Mark RPrausnitz ,“Microneedles for transdermal drug delivery”, Advanced Drug Delivery Reviews,Volume 56, 2004, Pages 581-587
[30] W. Snehal, K. Nitin A, and D. Rekha et al., “Microneedle Advance Drug Delivery System.”, Journal of Pharmaceutical Research, Volume 3, 2013.
[31] Y. Ami, H. Tachikawa, and N. Takano et al., “Formation of polymer microneedle arrays using soft lithography.”, Journal of Micro/Nanolithography, MEMS, and MOEMS, Volume 10, 2011.
[32] Eneko Larrañeta,Rebecca E.M. Lutton, A. David Woolfson, Ryan F. Donnelly, “Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development.”, Materials Science and Engineering: R: Reports, Volume 104, 2016, Pages 1-32
[33] Alexander A, Dwivedi S, “ Ajazuddin. Approaches for breaking the barriers of drug permeation through transdermal. ”,Journal of Controlled Release. ,Volume 164, 2012,Pages 26-40.
[34] Chen MC, Ling MH, Setiawan JK.,“Poly-γ-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin. ”, Acta biomaterialia. ,2015
[35] Patwekar SL, Gattani SG, Pande MM. ,“Needle free injection system: A review. ”, International Journal of Pharmacy and Pharmaceutical Sciences,Volume 5,2013,Pages 14-19
[36] Anubhav Arora, Mark Prausnitz,Samir Mitragotri ,“Micro-scale Devices for Transdermal Drug Delivery. ”, Int J Pharm.,Volume 364,2008,Pages 227-236
[37] 華展生醫,<核心技術-無針式液體藥物注射器簡介>,http://www.gntbmd.com/technology.php
[38] 京華堂實業股份有限公司(2017)。專利編號M539954。臺北市:經濟部智慧財產局
[39] Huang YH, Hu CS, Ke YJ, Chiang CH, Hong PD, Yeh MK, “Evaluating the effectiveness of a novel atomized liquid needle-free transdermal delivery system.”,Drug Deliv Transl Res.,Volume 7,2017, Pages 609-616
[40] Huang YH, Chen CY, Chen PJ, Tan SW, Chen CN, Chen HM, Tu CS, and Liang YJ,“Gas-injection gold nanoparticles and anti-oxidatants promotes the diabetic wound healing,” RSC Advances, Volume 4, 2014, Pages 4656-4662
[41] Pastila R., Effect of long-wave UV radiation on mouse melanoma: an in vitro and in vivo study, Finland: Stuk, 2006, Pages 4
[42] Yoshida Y., Hachiya A., Sriwiriyanont P. et al., “Functional analysis of keratinocytes in skin color using a human skin substitute model composed of cells derived from different skin pigmentation types”, The FASEB Journal, Vol. 21, No. 11, 2007, Pages 2829-2839
[43] Solano, F., S. Briganti, M. Picardo, and G. Ghanem, “Hypopigmenting agents: an updated review on biological, chemical and clinical aspects.” Pigment Cell Res., Volume 19, 2006, Pages 550-571.
[44] Chan Y.Y., Kim K.H., Cheah S.H., “Inhibitory effects of Sargassum polycystum on tyrosinase activity and melanin formation in B16F10 murine melanoma cells,” Journal of Ethnopharmacology, Vol. 137, No. 3, 2011, Pages 1183-1189
[45] Abdel-Malek Z., Swope V. B., Suzuki I., “Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 92, No. 5, 1995, Pages 1789-1793
[46] 蕭伊妙,「維他命C醣苷和熊果素對於B16色素素瘤細胞抑制色素生成之研究」,碩士論文,國立清華大學,新竹,2007[47] Mirosława Cichorek, Małgorzata Wachulska, Aneta Stasiewicz, Agata Tymińska, “Skin melanocytes: biology and development ,” Postepy Dermatol Alergol.,Volume 30.2013,Pages 30-41
[48] Slominski A., Tobin D. J., Shibahara S., “Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation,” Physiological Reviews, Vol. 84, No. 4, 2004, Pages 1155-1228
[49] Chan Y.Y., Kim K.H., Cheah S.H., “Inhibitory effects of Sargassum polycystum on tyrosinase activity and melanin formation in B16F10 murine melanoma cells,” Journal of Ethnopharmacology. Vol. 137, No. 3, 2011, Pages 1183-1188
[50] 呂佩嘉、黃蕙君、張聰民,「生薑醇抑制黑色素生成之研究」,弘光學報,弘光科技大學,台中,2009
[51] 周玉青、黃蕙君、張聰民,「莨菪素抑制酪胺酸酶功效之研究」,弘光學報,弘光科技大學,台中,2009
[52] 王阿靜,「化妝品美白成分之HPLC分析方法開發」,碩士論文,朝陽科技大學,台中,2004[53] 陳世芬,「高濃度常溫安定性熊果素微脂粒脂之製備與評估」,碩士論文,樹德科技大學,高雄,2010[54] Kazuhisa S., Takahisa N., Koji N. et al., “Syntheses ofα-Arbutin-α-Glycosides and Their Inhibitory Effects on Human Tyrosinase”, Pharmaceutical Society of Japan, Vol. 99, No. 3, 2005, Pages 272-276
[55] 王阿靜,「化妝品美白成分之HPLC分析方法開發」,碩士論文,朝陽科技大學,台中,2004
[56] Tsaib Y. H., Leeb K. F., Huanga Y. B. et al., “In vitro permeation and in vivo whitening effect of topical hesperetin microemulsion delivery system”, International Journal of Pharmaceutics, Vol. 388, No. 1, 2010, Pages 257-262
[57] Ishii H., Fujino K., Todo H. et al., “Evaluation of the skin blanching of topically applied steroids using a chroma meter in animals”, Experimental Animals, Vol.61, No.2, 2012, Pages 147-156
[58] Xiaoyan Q., Yujin W., Bangfeng W., “Fast color contrast enhancement method for color night vision”, Infrared Physics & Technology, Vol. 55, No. 1, 2012, Pages 122-129
[59] Mustafa Q. Yousif, Shadi A. Qasem, Skin Tissue Engineering and Regenerative Medicine, Nederland: Elsevier, 2016, Pages 49-59
[60] LAWRENCE E. GIBSON M.D., “Amelanotic Melanoma: Cases Studied by Fontana Stain, S-100 Immunostain, and Ultrastructural Examination”, Mayo Clinic Proceedings, Volume 63, Issue 8, August 1988, Pages 777-782